Clinical and Economic Impact of a Multidisciplinary Follow-Up Program in Lymphoma Patients.
Fiche publication
Date publication
mai 2022
Journal
Cancers
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BASTIE Jean-Noël, Dr CAILLOT Denis, Dr CASASNOVAS Olivier, Dr MOUNIER Morgane, Dr ROSSI Cédric
Tous les auteurs :
Devaux M, Boulin M, Mounier M, Caillot D, Ahwij N, Herbin A, Bastie JN, Favennec C, Robert P, Pistre P, Bost S, Amiot P, Jacquesson L, Casasnovas O, Rossi C, Gueneau P
Lien Pubmed
Résumé
The UMACOACH Lymphoma is a multidisciplinary monitoring program for patients initiating a first highly haematotoxic treatment for Hodgkin or non-Hodgkin lymphoma. Patient follow-up is based on consultation with a pharmacist and planed phone calls by nurses supervised by a clinical haematologist. Our objective was to assess effectiveness and cost of the UMACOACH Lymphoma Program (ULP) and to investigate patient satisfaction and quality of life (QoL).
Mots clés
follow-up, haematotoxicity, immunochemotherapy, lymphoma, nurse, pharmacist, quality of life
Référence
Cancers (Basel). 2022 05 21;14(10):